10.09.2024
Therapeutics
$2,034,990.00
36 months
Determining the Therapeutic Potential of Statins on Stricturing Crohn's Disease
Current CD therapeutics do not address the fibrosis underlying stricture formation. Statins are known to have anti-inflammatory and anti-fibrotic effects, and their repurposing for use in CD would expedite the drug development process. This project will establish the efficacy of statins to prevent stricture recurrence and expand the growing evidence for further therapeutic development.